Shilpa Medicare Sets Issue Price For Rs 500-Crore QIP

The QIP will result in equity dilution of 11.24% after the issue.

Shilpa Pharma Life Sciences - Unit II. (Source: Shilpa Medicare website)

Shilpa Medicare Ltd. has opened its qualified institutional placement of equity shares on Monday and set the issue price at Rs 477.33 apiece.

The issue price indicates a 10% discount to Monday's closing price. It will close on Tuesday, according to the term sheet reviewed by NDTV Profit.

The QIP will result in equity dilution of 11.24% after the issue.

The board had approved the fundraising plan of up to Rs 500 crore in February, which received the shareholders' nod last month.

Shilpa Medicare is a Karnataka-based pharmaceutical company engaged in research and development, manufacturing and sale of oncology and non-oncology APIs (active pharmaceutical ingredient), finished formulations, biologicals, ODF, derma, peptides and polymers, among others.

Shares of the company closed 2.12% higher, ahead of the announcement, as compared with a 0.67% advance in the benchmark BSE Sensex.

Also Read: Shilpa Medicare Shares Jump 5% On Oral Drug Delivery System Nod

Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
WRITTEN BY
Shubhayan Bhattacharya
Shubhayan covers markets and business news at NDTV Profit. He has a keen in... more
GET REGULAR UPDATES